285 related articles for article (PubMed ID: 2402929)
1. [The value of cytoreductive second-look surgery in advanced epithelial ovarian carcinoma].
Sevelda P; Barrada M; Vavra N; Denison U; Schmidl S; Genger H; Salzer H
Wien Klin Wochenschr; 1990 Aug; 102(15):441-3. PubMed ID: 2402929
[TBL] [Abstract][Full Text] [Related]
2. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer.
Gadducci A; Iacconi P; Fanucchi A; Cosio S; Teti G; Genazzani AR
Anticancer Res; 2000; 20(3B):1959-64. PubMed ID: 10928134
[TBL] [Abstract][Full Text] [Related]
3. Secondary cytoreductive surgery at second-look laparotomy in advanced ovarian cancer: a Gynecologic Oncology Group Study.
Williams L; Brunetto VL; Yordan E; DiSaia PJ; Creasman WT
Gynecol Oncol; 1997 Aug; 66(2):171-8. PubMed ID: 9264559
[TBL] [Abstract][Full Text] [Related]
4. Second-look laparotomy for ovarian cancer provides reliable prognostic information and improves survival.
Friedman RL; Eisenkop SM; Wang HJ
Gynecol Oncol; 1997 Oct; 67(1):88-94. PubMed ID: 9345362
[TBL] [Abstract][Full Text] [Related]
5. Long-term survival in advanced ovarian cancer after cytoreduction and chemotherapy treatment.
Del Campo JM; Felip E; Rubio D; Vidal R; Bermejo B; Colomer R; Zanon V
Gynecol Oncol; 1994 Apr; 53(1):27-32. PubMed ID: 8175018
[TBL] [Abstract][Full Text] [Related]
6. Impact of second look laparotomy and secondary cytoreductive surgery at second-look laparotomy in ovarian cancer patients.
Obermair A; Sevelda P
Acta Obstet Gynecol Scand; 2001 May; 80(5):432-6. PubMed ID: 11328220
[TBL] [Abstract][Full Text] [Related]
7. Second-look laparotomy in stage III epithelial ovarian cancer: clinical variables associated with disease status.
Berek JS; Hacker NF; Lagasse LD; Poth T; Resnick B; Nieberg RK
Obstet Gynecol; 1984 Aug; 64(2):207-12. PubMed ID: 6539884
[TBL] [Abstract][Full Text] [Related]
8. Impact of secondary cytoreductive surgery on survival of patients with advanced epithelial ovarian cancer.
Zang RY; Zhang ZY; Li ZT; Cai SM; Tang MQ; Chen J; Liu Q
Eur J Surg Oncol; 2000 Dec; 26(8):798-804. PubMed ID: 11087649
[TBL] [Abstract][Full Text] [Related]
9. [Value of tumor-reductive secondary operation (interventional laparotomy) in ovarian cancer].
Meier W; Römisch M; Hepp H
Geburtshilfe Frauenheilkd; 1993 Dec; 53(12):860-5. PubMed ID: 8119569
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic strategy in the management of stage II-IV epithelial ovarian carcinoma.
Sun T; Feng Y; Zhu Y; Zheng Y
Chin Med J (Engl); 2000 Jul; 113(7):625-7. PubMed ID: 11776033
[TBL] [Abstract][Full Text] [Related]
11. Times and sites of relapses after negative second look in advanced epithelial ovarian cancer.
Maggino T; Gadducci A; Romagnolo C; Fanucchi A; Fioretti P
Eur J Surg Oncol; 1994 Apr; 20(2):146-50. PubMed ID: 8181580
[TBL] [Abstract][Full Text] [Related]
12. Intravenous chemotherapy, early debulking surgery, and consolidation intraperitoneal chemotherapy in advanced ovarian carcinoma.
Tournigand C; Louvet C; Molitor JL; Dehni N; Lejeune V; Sezeur A; Pigne A; Marpeau L; Cady J; de Gramont A
Gynecol Oncol; 2001 Nov; 83(2):198-204. PubMed ID: 11606072
[TBL] [Abstract][Full Text] [Related]
13. [Surgical therapy of ovarian carcinoma].
Sevelda P
Wien Med Wochenschr; 1996; 146(1-2):18-22. PubMed ID: 8835491
[TBL] [Abstract][Full Text] [Related]
14. Secondary cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma.
Scarabelli C; Gallo A; Carbone A
Gynecol Oncol; 2001 Dec; 83(3):504-12. PubMed ID: 11733963
[TBL] [Abstract][Full Text] [Related]
15. Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response.
Vaccarello L; Rubin SC; Vlamis V; Wong G; Jones WB; Lewis JL; Hoskins WJ
Gynecol Oncol; 1995 Apr; 57(1):61-5. PubMed ID: 7705701
[TBL] [Abstract][Full Text] [Related]
16. Stage III-IV epithelial carcinoma of the ovary: is the second-look operation of any value for the patient?
Atad J; Bornstein J; Steiner M; Weill S; Lurie M; Abramovici H
Isr J Med Sci; 1988 Nov; 24(11):660-3. PubMed ID: 3215758
[TBL] [Abstract][Full Text] [Related]
17. Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy.
Petit T; Velten M; d'Hombres A; Marchal C; Montbarbon X; Mornex F; Quetin P; Gérard JP; Romestaing P; Carrie C
Gynecol Oncol; 2007 Jan; 104(1):104-8. PubMed ID: 16987544
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors for outcome of and survival after second-look laparotomy in patients with advanced ovarian carcinoma.
Lund B; Williamson P
Obstet Gynecol; 1990 Oct; 76(4):617-22. PubMed ID: 2216190
[TBL] [Abstract][Full Text] [Related]
19. Epithelial ovarian carcinoma: principles of primary surgery.
Hoskins WJ
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S91-6. PubMed ID: 7835815
[TBL] [Abstract][Full Text] [Related]
20. Role of salvage cytoreductive surgery in the treatment of patients with recurrent ovarian cancer after platinum-based chemotherapy.
Matsumoto A; Higuchi T; Yura S; Mandai M; Kariya M; Takakura K; Fujii S
J Obstet Gynaecol Res; 2006 Dec; 32(6):580-7. PubMed ID: 17100820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]